Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DK-21-012

Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)

Closed on October 7, 2022.

Posted
May 19, 2021
Close date
October 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$299,182
$598,364 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. IMMUNOSHIELD THERAPEUTICS INC.1
  2. STEMBIOSYS, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-J (O2))1
  2. Special Emphasis Panel (ZDK1 GRB-T (M1))1
2 awards under RFA-DK-21-012 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation1R43DK135102-01Navarro, Mary MSTEMBIOSYS, INC., TXFirst-year cost $300,000Study section ZDK1
FY2023Islet dosing and loading density in injection molded macroencapsulation devices1R43DK136496-01Snir, OrenWeaver, Jessica DianeIMMUNOSHIELD THERAPEUTICS INC., AZFirst-year cost $298,364Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.